ARCHIVES

Evidence Too Weak to Link Agent Orange, Cancer, IOM Says

This article is from The Cancer Letter archive.

Vol. 28 No. 12 | March 22, 2002

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Taxol For Metastatic Breast Cancer

January 7, 1994

Biomedical Panel Says Cancer Panel Should Expand to Serve all NIH

June 4, 1976

IOM, NCI Clash Over Proposed Change in Tabulating Minority Research

January 22, 1999

NCI Raises New Questions About Duke Genomics Research, Cuts Assay From Trial

May 14, 2010

ELM’s CHOP-DS Aims For 15% Of Patients

September 13, 1985

Upton Explains New NCI System: Rants Funded “Across The Board” Strictly By Priority Score

August 25, 1978